Swiss pharmaceutical giant Novartis is poised to expand its profile in the San Diego area, announcing plans to acquire Regulus Therapeutics, a local company on the cusp of bringing a potential ...

Novartis said it plans to build six new manufacturing plants, some of which will make raw pharmaceutical ingredients, as well as open a second global biomedical research hub in San Diego.

SAN DIEGO (FOX 5/KUSI) — Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San Diego as part of a wider effort to expand its ...

SAN DIEGO — Novartis, a Swiss pharmaceutical company, announced a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure. The move ensures that ...

Swiss pharmaceutical firm Novartis on Tuesday reported better-than-expected first-quarter sales and raised its full-year guidance. Stream San Diego News for free, 24/7, wherever you are with NBC 7.

Basel, April 30, 2025 – Novartis today announced that it has entered into an agreement to acquire Regulus Therapeutics, a San Diego-based, publicly traded (Nasdaq: RGLS) clinical-stage ...

Novartis, a global innovative medicines company ... The investment includes a newly planned $1.1 billion research hub in San Diego, a state-of-the-art research facility that will provide world ...

Pharmaceutical company Novartis said it plans to expand U.S ... its R&D activity with a new $1.1 billion research hub in the San Diego area, its second in the U.S. The new complex is expected ...

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO, June 04, 2025--Biocom California, the association representing the California life science industry, today announced the appointment of Thierry ...

Last July, Novartis announced plans to close one of its San Diego research sites on Campus Point Drive by mid-2025 as part of a broader restructuring of its drug development segment.